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ABSTRACT 
Film forming  topical formulation is solutions / sprays , gels , emulsion are a novel approach is as an alternative to the conventional dos age 
formed  used on the topically on skin , such as ointment , creams or patches .The polymeric solution is an applied to the ski n as a liquid and 
forms a transparent invisible film by solvent evaporation the aim of this review was to search for alternatives to the conven tional dosage forms 
.it is a novel approach helpful in providing  sustained release drug delivery system with increase resistance time  ,reduce skin irritation , 
improve skin adhesion property , increase drug  release  and increase patient comfortability. 
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INTRODUCTION :- 
Skin is an important route of administration of drugs for 
both  local& systemic effect. (1)Topical  therapy effect 
depends on a physiochemical properties of the drug and 
excipient  and ability  adhere to the skin during treatment so 
as to promote   the drug penetration through skin barrier 
(1). The skin is an most rapidly accessible organ of the body 
& acts as a barrier against  the macro &micromolecules of 
the environment because of its low permiability to such 
substances (1-4) & surface  area of about 2m recieiving 
about one third of the total blood circulating throughout the 
body (2-4). 
The  topical  route offers as a large surface & ease to the 
application via self administration& provides an alternative 
to oral drug delivery as well as hypodermic injection.(2) 
Percutaneous absorption of drug content through skin 
mainly occurs via stratum corneum. (1) stratumcorneum is a 
thin , outer layer of skin consisting of both hydrophilic & 
lipophilic  domain , hair follicle and sweat gland , stratum 
corneum has a water content of 20% which lies in keratin 
layer between horny cells . keratin is 20% cross linked 
which lies in keratin layer between horny cells.(4) 
The recent dosage forms i.e. patches , ointment , creams , etc 
are associates with several limitations . film forming system 
(FFS) it is a novel approach which can be used as an 
alternative to conventional topical and trasdermal 
formulation (4).It is defined as non-solid dosage form it 
produces a film in situ i.e. after application on the skin. The 
formed  film can either be a solid polymeric material that 
acts matrix for sustained release of drug to the skin or a 
residual liquid films which is rapidly  absorbed  in the 
stratum (4-10) 
The need for multiple applications on a day is frequently 
associated with poor compliance of patients . Thus 
prolonging the existing time of active substances to the skin 
& thereby reducing the application frequency is a subject of 
intensive research (7).The formed film is an sufficiently 
substantial to provide a sustained drug release to the 
skin.(2) 
Film Forming Solution (FFS) (7)  may be 
    -solution 
    - gel 
    - emulsion 
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1.1 Sprays/solutions 
Film forming solutions and sprays it  is an attractive and 
novel approachin transdermal sustained drug delivery 
system. In this the polymeric drug solution isapplied to the 
skin as a liquid/solution or sprayed on the skin and form 
asan almost transparentthin  film by solvent evaporation [9]. 
The film forming sprays/solutions are made up of four 
maincomponents – drug, solvent systems i.e. volatile and 
nonvolatilevehicles, polymers and penetration 
enhancers.The nonvolatilecomponent present in the solvent 
system prevents thedrug from precipitating in solution 
when the volatile solventcomponent evaporates. (7,8 ) The 
non-volatile component is chosensuch that it itself partitions 
rapidly into the stratum corneumand also aid in partitioning 
of the drug into the stratumcorneum, as well as increases 
drug diffusivity by distracting  theordered intercellular 
lipids and enhance permeation through skin. This typeof 
delivery system creates an invisible depot of drug in 
thestratum corneum from which the drug can be slowly 
absorbedinto the systemic circulation. Thus a sustained and 
improve  permeation of drug across the skin can be achieved 
by following once a day application (7,8). In formulation 
preparation involves addition of thepolymer to the vehicle 
and stirring of the solution overnight to ensure complete 
dissolution of the polymer. Once a clearpolymeric solution is 
obtained other optional excipients suchas cross linker or 
plasticizer are added. After addition of all excipientsthe 
solution is stirred for 24 h (9). For the physicalstability of 
the API, the polymers are chosen such that they functionas 
anti-nucleating agents and crystallization inhibitorswhich 
prevent crystallization of drug even after solvent 
evaporation e.g. polyvinyl pyrrolidone, polyethylene glycol, 
hydroxylpropyl methyl cellulose.Film forming solutions can 
be applied with an a applicatorto the skin and allowed to 
dry. Film forming spray is manufacturedas a metered dose 
pump dispenser to supply or give fixedamount of drug and it 
is sprayed on the topical site to form a transparent film. 
These systems form a stable fast drying, non-irritating 
invisible film from which the drug is available for 
transdermaltherapy (9). Following administration, the film 
can bepeeled off once the desired results are obtained or for 
the terminationof therapy .Misra et al. prepared a liquid film 
forming solution using a mixture of polyvinyl pyrrolidone 
and polyvinyl alcohol in isopropanolas film forming 
polymeric solutions for the biphasicdelivery of testosterone 
(10). Ammar et al. developed a filmforming polymeric 
solution of ketorolac using Eudragit and polyvinyl 
pyrrolidone in ethanol as film forming agents (9). The 
mechanical property and appearance of the prepared 
formulations was   evaluated.Gohel and Nagori developed a 
fluconazole spray containingethyl cellulose and Eudragit RS 
100 as film formers (11).Yuet al. developed transdermal 
film-forming spray containing estradioland optimized the 
formulation using different polymersand plasticizers for 
efficient penetration of estradiol for longerduration of time 
as compared to gel and patch (12). 
1.2. Gels 
Gels it is a semisolid dosage form containing both solidand 
liquid components. The liquid component may be 
hydrophobic or hydrophilic in nature, immobilized in a 
threedimensional network of the interconnected solid 
components(13). Hydrogels are the aqueous gels 
containinghydrophilic polymers that form three dimensional 
network inwater(14).It’s is a non fluid colloidal network that 
is expanded throughout its whole volume by a fluid (6) 
The administration of film forming gel involves applying a 
doseon the arms, shoulders, internal parts of the thighs or 
abdomento form a thin bioadhesive film on the skin (23) 
The drug substance is dissolved in film forming vehicle and 
is thusincorporated in the film formed on skin. The film can 
functionas an external reservoir or limit the supply of drug 
substance to the skin thereby controlling the release ofdrug 
(15). 
Complete skin contact with the entire application is 
essential;therefore, the formulation requires high flexibility 
to adjust  the movement of the skin, high substantivity, 
strong adhesion to the skin for stable n contineous delivery 
and absorption of drug. 
Hence, along with gelling agents, film forming agents, 
plasticizers,preservatives etc. are used in the formulation. 
Compared with other forms, these systems offer 
easieruseandapplication,appropriate consistency and 
adhesiveness, good flexibilityand elasticity and ease of 
manufacturing (16). 
Film forming hydrogels are majorly used in wound 
healing.The formulation applied to the wounded site 
provides a filmthat is resistant to physiological stress caused 
by the movementof skin. 
1.3. Emulsions 
Emulsions are a semisolid or liquid preparations having the 
abilityto solubilize both lipophilic and hydrophilic drugs. 
Pharmaceuticalemulsions consist of mixtures of aqueous 
phase and oily phase stabilized by suitable emulsifying 
agents (17).These canbe oil-in-water (O/W) emulsions (oil 
phase is dispersed in thewater phase) or water-in-oil (W/O) 
emulsions (water phase dispersedin an oily continuous 
phase).The type of emulsion formeddepends mainly on the 
type of emulsifiers, which is characterizedby the 
hydrophilic–lipophilic balance (HLB). The HLB is ascale from 
1 to 20 and the higher the HLB, the more hydrophilicis the 
surface active agent. An emulsifying agent it is asubstance 
which stabilizes the emulsion. There are differenttypes of 
emulsifying agents including surfactants, polymers, 
proteins(gelatin) and finely divided solid particles 
(bentonite).Film forming emulsions, in addition to the oil 
phase and theaqueous phase, contain film forming 
polymer.The volatile componentspresent in the emulsions 
evaporate leading to thechanges in the tissue, allowing 
absorption of the drug (18).Theadvantage of film forming 
emulsions over semisolid formulationsis that, it allows 
treatment of larger areas of affected skinwith an extended 
contact time and adequate substantivity, thusallowing 
sustained dermal therapy of chronic diseases (19).The 
delivery of the drug through skin depends on a natureof the 
API and the type of emulsion. The dermal delivery of the 
lipophilic sunscreen agent ethylhexylmethoxycinnamatewas 
higher from the W/O emulsion than from the O/W 
emulsionmost probably because of the occlusive effect of the 
oilyvehicle. But other studies have shown a discrepancy. It 
was observedthat the skin permeation of lipophilic parabens 
wasenhanced from O/W emulsions compared with the W/O 
emulsion.This was explained by a higher affinity of the 
parabensfor the vehicle than for the stratum corneum in the 
case ofthe w/oemulsion(17). 
FFS creates supersaturated systems immediately after 
applicationto the skin, overcoming the problem of 
instability.Thusit improves the drug permeation through 
skin compared toother transdermal dosage forms.shown in 
fig.1
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Fig. 1 – Release profile of the topical and transdermal drug delivery system. 
 
2. EVALUATION OF FILM FORMING SYSTEM 
2.1. Film formation 
The films are formed in a Petri dish or on an excised pig ear 
skin. Film-formation it is evaluated and rated as absolute or 
complete and uniform, incomplete or non-uniform, with or 
without precipitation of the film-forming polymer.The 
cosmetic aspects of the film are given in terms of 
transparency or opaque, sticky or dry, peelable or non-
peelable(21). 
2.2. Film flexibility 
Film flexibility is evaluated on the basis of reaction of skin 
cracking and skin fixation and this is determined by 
stretching the skin in 2–3 directions. The film is rated 
flexible if there is no cracking or skin fixation and non-
flexible if there is cracking and skin fixation. 
2.3. Drying time 
 drying time the formulation is evaluated by the formulation 
is applied to the inner sides of the forearm of a volunteer. 
After a fixed time period a glass slide is placed on the film 
without pressure.If no liquid is visible on the glass slide after 
removal, thefilm is considered dry (22). If remains of the 
liquid are visible on the glass slide the experiment is 
repeated with an increase in drying time. A good FFS should 
have a minimumdrying time to avoid long waiting time for 
the patient. 
2.4. Stickiness 
The stickiness of the film formed is determined by 
pressingcotton wool on the dry film with low pressure. 
Depending onthe quantity of cotton fibres that are retained 
by the film, thestickiness is rated high if there is dense 
accumulation of fiberson the film, medium if there is a thin 
fiber layer on the filmand low if there is an occasional or no 
adherence of fibers. Thisevaluation parameter is essential, as 
the formulation shouldbe non-sticky to avoid adherence to 
the patients’ clothes (23). 
2.5. Mechanical properties 
The  polymeric films are produced by solvent evaporation on 
a Teflon plate and mechanical properties of the films are 
determined with a tensile tester after the films are dry and  
cut with the help of a scalpel. Film thickness is measured 
with a digital micrometer. 
2.6. Determination of the water vapor permeability 
The water vapor permeability is defined as the quantity of 
water transmitted through a unit area of film in unit 
time.These water vapor permeation data are important in 
determining the permeation characteristics of the film as 
they have influence on skin properties like hydration of 
stratum corneum, blood flow, and skin temperature (25). 
Films are produced with a solvent evaporation technique on 
a Teflon plate and dried for 72 h at room temperature. 
Circular samples are cut from the dry film sheets and this 
sheets use for cover the sample preparation glass vials. For 
the sample preparation glass vials  are filled with distilled 
water, covered with the circular film.samples and a silicone 
ring, and sealed tightly with an aluminum vial cap.The 
weight of the vial is determined and then placed into a 
desiccator creating an atmosphere of 58% relativehumidity 
or low relative humidity (approximately 0%).They are kept 
at a determined temperature for 72 h and weighed after 
predetermined intervals. From the weight loss of the vials 
W(g) the water vapor permeability is calculated as the 
amount of water that permeates through the film in relation 
to the surface area A (cm2) and the time t (h) (24): 
2.7. Swab studies 
Swab test can be performed to evaluate the residence time 
offilm forming system. For adhesion testing, glass was used 
as apolar, hydrophilic substrate. Glass was chosen as test 
surfacebecause films adhering strongly to it would also show 
strongadherence to skin because both materials display a 
polar surfacestructure (26).Dry swab test: This test indicate 
the behavior of FFS on the dry skin  condition. Dry swab test 
can be carried out on a glass plate.The glass plate is marked 
with 6 squares of 1 × 1 cm2. Developed formulation is 
applied in this area.  Swabbing on the applied film is carried 
out at 0 min, 30 min, 2 h, 4 h, 6 h and 8 h and checkedfor 
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drug content after extraction of drug from the swab.Wet 
swab test: This test depicts the activities of FFS when it 
comes in contact with water or sweat.The procedure for the 
wet swab test, dry swab test is the same as except the swab 
taken is soaked in water before and then the formulations 
areswabbed with this wet swab. 
2.8. Film topography 
Atomic force microscopy (AFM) provides information about 
thetopographic and mechanical properties of the polymeric 
filmsand helps to match the mechanical properties of the 
formedfilms to those of skin. It generates a nanoscale image 
of thefilm’s homogeneity and roughness and requires no 
special treatmentprior to the measurement (27). 
2.9. Film homogeneity 
Raman spectroscopy provides information about the 
chemicalcomposition of the polymeric films. The chemical 
mapsobtained from Raman spectra provide a measure of 
chemicalhomogeneity of films. Techniques based on Raman 
scatteringcan also be used to track the permeation of 
topically appliedcompounds through the skin (27). 
2.10. In vitro diffusion study 
The in vitro diffusion studies are used to predict the 
permeationcharacteristics of drug in vivo. Franz diffusion 
cell is used to determine the release profile of the drug from 
the filmforming system.The cell is made up of two 
compartments, thedonor and the receiver compartment 
between which the diffusionmembrane is attached (egg 
membrane or cellophane).The donor compartment is 
exposed to the atmosphere and thereceptor compartment 
contains the diffusion medium.The samplingarm in the 
receptor compartment allows for sampling.Predetermined 
quantity of the drug containing film formingformulation is 
placed on the donor compartment. Samples arecollected and 
analyzed by suitable spectroscopic method fordrug release 
(23). 
2.11. Ex vivo permeation study 
The ex vivo permeation studies are performed to study 
theeffects of skin barrier on the developed film forming 
system.Franz diffusion cell/Keshary–Chien diffusion cell can 
be usedfor permeation study. Rat’s skin is mounted between 
the twocompartments, stratum corneum facing the donor 
compartmentand dermis facing the receptor compartment. 
Theformulation is applied to the skin surface which forms a 
filmafter drying. The receptor compartment contains 
phosphatebuffered saline (pH 7.4) maintained at 37 •} 0.5 
°C. Aliquots arecollected at specific time intervals and 
analyzed by suitablespectroscopic method (28). 
2.12. Skin penetration studies 
The formulation is applied evenly on the skin using a 
pipetteor a spatula. After fixed time intervals (e.g. 15 min, 1 
h, 3 h, 6 h,8 h, etc.) post application, the remaining 
formulation is removed.The film is wiped off with the help of 
cotton pads and theamount of drug present in the cotton 
pads is calculated, whichis equivalent to the amount of drug 
remaining in the film.Therefore the amount of drug 
penetrated can be calculated bysubtracting the 
remainingamount from the total amount ofdrug present in 
the formulation (29). 
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